Beta-amyloid levels predict cholinesterase activity in human cerebrospinal fluid

R T Carroll1, M R Lust, M R Emmerling

  • 1Neuroscience Therapeutics, Parke-Davis Pharmaceutical Research Division, Warner-Lambert Co., Ann Arbor, MI 48106, USA.

Neuroreport
|March 27, 1999
PubMed